
SCABY News Today: Stay Updated with the Latest Svenska Cellulosa Aktiebolaget SCA (publ) News in Real Time
Find SCABY news now at Meyka AI. Stay informed with the latest Svenska Cellulosa Aktiebolaget SCA (publ) stocks updates, including price news, market analysis, and expert insights.

Palace Accused of Covering Up Andrew’s Trade Secret Leaks, June 01
Epstein survivor accuses Buckingham Palace of covering up Andrew Mountbatten-Windsor’s alleged classified information leak.

LBGUF Earnings Beat: L E Lundbergföretagen Q2 2026 Results
LBGUF reported Q2 2026 earnings on May 21, 2026 with $2.02 EPS and $868.45M revenue. Meyka AI rates the stock B+.

Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD on PNK. Medical device company faces high valuation multiples despite strong 6-month gains of 40%.

H2APEX Group SCA Stock Slips 2% Ahead of Earnings Report
H2A.DE stock drops 1.96% on XETRA as green hydrogen producer prepares earnings announcement. Analysis of key metrics and outlook.

BRCTF Earnings Beat: BioArctic AB (publ) Crushes Q2 2026 Estimates
BioArctic AB (BRCTF) beat Q2 2026 earnings on May 20 with EPS of $0.2514 vs. -$0.0316 estimate and $46.04M revenue vs. $20.26M expected.

Touax SCA Stock Holds €5.48 as Leasing Giant Trades Above 50-Day Average
TOUP.PA stock trades at €5.48 on EURONEXT. Touax SCA, the industrial leasing company, holds steady with a neutral rating and 2.74% dividend yield.

NDRBF Earnings Beat: NIBE Industrier Q2 2026 Results
NDRBF beats EPS and revenue estimates in Q2 2026 earnings. NIBE Industrier reports $0.0263 EPS vs $0.0257 estimate, $1.02B revenue.

Beyond Frames Entertainment Stock Slips 1.9% Ahead of Earnings
8WP.F stock drops 1.9% to €0.207 on XETRA ahead of May 21 earnings announcement. Gaming firm faces profitability challenges.

Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD. Medical device maker faces elevated valuation metrics and mixed analyst outlook in healthcare sector.